SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001358403-17-000071
Filing Date
2017-05-08
Accepted
2017-05-08 16:05:28
Documents
3
Period of Report
2017-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kearningsreleaseqtr12017.htm 8-K 34537
2 EXHIBIT 99.1 qtr1-2017earningsreleaseex.htm EX-99.1 106336
3 qtr12017.jpg GRAPHIC 27677
  Complete submission text file 0001358403-17-000071.txt   180324
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 17822215
SIC: 2834 Pharmaceutical Preparations